BioPharma Credit PLC (OTCMKTS:BOPCF – Get Free Report) was the recipient of a significant growth in short interest during the month of April. As of April 30th, there was short interest totaling 3,486 shares, a growth of 113.3% from the April 15th total of 1,634 shares. Based on an average trading volume of 10,915 shares, the days-to-cover ratio is presently 0.3 days.
BioPharma Credit Stock Performance
OTCMKTS BOPCF opened at $0.90 on Friday. The company has a 50 day moving average price of $0.93 and a two-hundred day moving average price of $0.90. BioPharma Credit has a 12-month low of $0.83 and a 12-month high of $1.00.
About BioPharma Credit
BioPharma Credit (OTCMKTS: BOPCF) is a closed-end investment company that specializes in providing debt financing solutions to the global life sciences sector. The firm offers a range of credit products—including senior secured loans, convertible loans and royalty monetization structures—designed to meet the capital needs of biotechnology and pharmaceutical companies across pre-clinical, clinical and commercial stages. By focusing on secured and structured credit, BioPharma Credit seeks to deliver consistent income while managing risk through collateralized arrangements and diversified portfolios.
Since its inception in 2016, the company has built a track record of partnering with innovative drug developers and medical technology firms.
Read More
- Five stocks we like better than BioPharma Credit
- 3 Stocks to Own If Gas Prices Keep Rising
- 3 Crucial Aerospace Component Makers That Analysts Love
- Alphabet’s Googlebook Brings Gemini AI to PC Hardware
- Peloton Stock Gives Back Gains After Upbeat Earnings Report
Receive News & Ratings for BioPharma Credit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioPharma Credit and related companies with MarketBeat.com's FREE daily email newsletter.
